12/18
07:10 am
camp
CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
High
Report
CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
12/18
07:00 am
camp
CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
High
Report
CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
12/12
04:05 pm
camp
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/14
04:05 pm
camp
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/6
04:05 pm
camp
CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
Medium
Report
CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
10/1
08:00 am
camp
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
Low
Report
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01